Julia Y. Ljubimova

Nanomedicine Research Center, Cedars-Sinai Medical Center

Affiliated withCedars-Sinai Medical Center

Research Area

Biography

Julia Y. Ljubimova has not added Biography.
If you are Julia Y. Ljubimova and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 23	2014

Other Publications

Article	Year
Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro. Molecular cancer therapeutics\| PubMed ID: 14578463	2003
Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer\| PubMed ID: 15274074	2004
Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast cancer research : BCR\| PubMed ID: 15987446	2005
Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. Frontiers in bioscience : a journal and virtual library\| PubMed ID: 16146715	2006
Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. Investigative ophthalmology & visual science\| PubMed ID: 16186340	2005
Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery. Bioconjugate chemistry\| PubMed ID: 16536461	2006
Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis. Angiogenesis\| PubMed ID: 17109197	2006
Nanoconjugate based on polymalic acid for tumor targeting. Chemico-biological interactions\| PubMed ID: 17376417	2008
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid). Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 17630012	2007
Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine (London, England)\| PubMed ID: 18373429	2008
Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes. Brain research bulletin\| PubMed ID: 19828126	2010
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? NeuroImage\| PubMed ID: 20149882	2011
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid). Pharmaceutical research\| PubMed ID: 20387095	2010
Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models. PloS one\| PubMed ID: 20419092	2010
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20921419	2010
Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity. Cancer research\| PubMed ID: 21303974	2011
The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery. Biomaterials\| PubMed ID: 21514661	2011
New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery. International journal of pharmaceutics\| PubMed ID: 21550387	2012
Poly(methyl malate) nanoparticles: formation, degradation, and encapsulation of anticancer drugs. Macromolecular bioscience\| PubMed ID: 21793213	2011
The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochimica et biophysica acta\| PubMed ID: 21851850	2012
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PloS one\| PubMed ID: 22355336	2012
Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery. Journal of nanotechnology\| PubMed ID: 23024655	2010
Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers. Biomaterials\| PubMed ID: 23063368	2013
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid). International journal of molecular sciences\| PubMed ID: 23109877	2012
Biocompatible nanopolymers: the next generation of breast cancer treatment? Nanomedicine (London, England)\| PubMed ID: 23148535	2012
Gene expression changes in rat brain after short and long exposures to particulate matter in Los Angeles basin air: Comparison with human brain tumors. Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie\| PubMed ID: 23688656	2013
Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 23770212	2013
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment. Journal of drug targeting\| PubMed ID: 24032759	2013
Nanomedicine therapeutic approaches to overcome cancer drug resistance. Advanced drug delivery reviews\| PubMed ID: 24120656	2013
Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors. Neurosurgical focus\| PubMed ID: 24484247	2014
Multilayer films assembled from naturally-derived materials for controlled protein release. Biomacromolecules\| PubMed ID: 24825478	2014